Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-031363
Filing Date
2022-06-06
Accepted
2022-06-06 16:09:28
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2021a1_abvcbio.htm   iXBRL 10-K/A 82307
2 CERTIFICATION f10k2021a1ex31-1_abvcbio.htm EX-31.1 8221
3 CERTIFICATION f10k2021a1ex31-2_abvcbio.htm EX-31.2 8326
4 CERTIFICATION f10k2021a1ex32-1_abvcbio.htm EX-32.1 4194
5 CERTIFICATION f10k2021a1ex32-2_abvcbio.htm EX-32.2 4248
  Complete submission text file 0001213900-22-031363.txt   330999

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20211231.xsd EX-101.SCH 3228
7 XBRL DEFINITION FILE abvc-20211231_def.xml EX-101.DEF 16122
8 XBRL LABEL FILE abvc-20211231_lab.xml EX-101.LAB 34388
9 XBRL PRESENTATION FILE abvc-20211231_pre.xml EX-101.PRE 17099
11 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021a1_abvcbio_htm.xml XML 5285
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40700 | Film No.: 22998164
SIC: 2834 Pharmaceutical Preparations